Previous research has revealed that CDCP1 is a novel marker of triple-negative breast cancer [24] and promotes tumor progression via reduction of lipid-droplet abundance and stimulation of fatty acid oxidation [25]. Here, CDCP1 is linked to triple-negative breast carcinoma.